Heartburn drug could be key to preventing sickle cell pain crises in kids
NCT ID NCT05084521
Summary
This study tested whether famotidine, a safe and widely used heartburn medication, could help children with sickle cell disease. Researchers gave the drug to 30 children for 29 days to see if it reduced a specific marker of blood vessel inflammation linked to painful blockages. The goal was to gather evidence to support a larger trial testing if this inexpensive drug can prevent the severe pain crises common in this disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Necker - Enfants malades Hospital; Department of Pediatrics and Infectious Diseases
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.